Orange Book product · Brand (NDA)
CYSTAGON
CYSTEAMINE BITARTRATE
Brand (NDA)NDA 020392RX MYLAN
At a glance
Aug 15, 1994
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 15, 1994
32 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
CYSTEAMINE BITARTRATE
Strength
EQ 150MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 020392
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
